The results of NR4A2 knockdown in colon cancer cells confirmed the pro-oncogenic activity of this gene and was similar to that previously observed for NR4A2 other cancer cell lines [23] and consistent with the unfavorable prognosis for colon cancer patients that overexpress NR4A2. This evidence concerns the gene NR4A2 and malignant colon neoplasm.